SHARE THIS VIDEO —
Coronavirus: Inside the first-of-its-kind genetic vaccine trial
This version of Mmvo83092037727 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.
Researchers at NYU have started clinical trials on a new vaccine developed by Pfizer and a German partner. The vaccine attempts to reprogram the genetic code of the coronavirus rather than manipulate the live virus so that the body will produce antibodies to fight off COVID-19.
NBC News Clone will keep curating essential reads for you — simplified and optimized.
